Recent articles








Synopsys' Growth Accelerates

The semiconductor software specialist raises its full-year guidance again after another strong quarter.







Unity Biotech: Buy at the Low?

Shares have been mired in a nearly continuous slide for the last year. Is Wall Street's pessimism misplaced?